Generation Bio Co
General ticker "GBIO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $85.4M
Generation Bio Co follows the US Stock Market performance with the rate: 5.1%.
Estimated limits based on current volatility of 8.2%: low 0.98$, high 1.15$
Factors to consider:
- Company does not operate outside North America (retrieved using AI)
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.99$, 3.36$]
- 2024-12-30 to 2025-12-30 estimated range: [1.28$, 3.91$]
Financial Metrics affecting the GBIO estimates:
- Negative: Non-GAAP EPS, $ of -1.96 <= 0.10
- Negative: Operating profit margin, % of -95.91 <= 1.03
- Negative: Operating cash flow per share per price, % of -33.12 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term GBIO quotes
Long-term GBIO plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $5.90MM |
| Operating Expenses | $119.10MM | $141.18MM | $144.47MM |
| Operating Income | $-119.10MM | $-141.18MM | $-138.56MM |
| Non-Operating Income | $-0.05MM | $4.54MM | $11.95MM |
| Interest Expense | $0.05MM | $0.00MM | $0.00MM |
| R&D Expense | $85.25MM | $96.72MM | $93.62MM |
| Income(Loss) | $-119.15MM | $-136.64MM | $-126.61MM |
| Profit(Loss) | $-119.15MM | $-136.64MM | $-126.61MM |
| Stockholders Equity | $381.75MM | $282.49MM | $203.13MM |
| Inventory | $0.00MM | $0.00MM | $0.19MM |
| Assets | $476.77MM | $376.26MM | $374.76MM |
| Operating Cash Flow | $-91.82MM | $-102.45MM | $-52.74MM |
| Capital expenditure | $5.96MM | $8.80MM | $7.40MM |
| Investing Cash Flow | $193.05MM | $-192.51MM | $-9.70MM |
| Financing Cash Flow | $214.67MM | $12.99MM | $35.82MM |
| Earnings Per Share* | $-2.04 | $-2.27 | $-1.96 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.